01/31/2025 6:07 AM | Novartis (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
01/31/2025 6:12 AM | Novartis (Filer)
| Form IRANNOTICE | |
01/31/2025 6:14 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2025 6:16 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024 5:05 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/25/2024 9:20 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/29/2024 5:20 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024 3:38 PM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/17/2024 4:08 PM | Novartis (Filer) Novartis Capital CORP (Filer)
| Form 424B5 | |
09/17/2024 1:05 PM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024 4:12 PM | Novartis (Subject)
| Form FWP | |
Get the Latest News and Ratings for NVS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Novartis and its competitors with MarketBeat's FREE daily newsletter.
|
09/16/2024 7:44 AM | Novartis (Filer) Novartis Capital CORP (Filer)
| Form 424B5 | |
09/16/2024 7:12 AM | Novartis (Filer) Novartis Capital CORP (Filer)
| Form F-3ASR | |
08/15/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC 13D/A | |
08/13/2024 3:31 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
08/12/2024 2:30 PM | Kowalski Robert William (Reporting) Novartis (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024 7:12 PM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
08/02/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
08/01/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
07/31/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
07/30/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
07/29/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
07/25/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
07/18/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
07/18/2024 5:09 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
07/05/2024 5:02 AM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T | |
06/21/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC 13D/A | |
06/20/2024 2:38 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-C | |
06/17/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC 13D/A | |
06/10/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC 13D/A | |
06/04/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
05/31/2024 5:00 AM | Novartis (Filer)
| Form SD Specialized Disclosure Report | |
05/22/2024 11:42 AM | Gal Aharon (Reporting) Novartis (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 3:31 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
05/07/2024 3:45 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
05/06/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
05/02/2024 3:31 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
04/25/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
04/23/2024 5:06 AM | Novartis (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Urgent Bitcoin alert for RIGHT NOW (Ad) Former billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 40-year career.
During the presentation, Larry reveals a strategy every trader and investor needs to understand.
He calls it “Bitcoin Skimming.” So please… click here to watch now. |
04/18/2024 3:31 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
04/18/2024 1:33 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC 13D | |
04/17/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
04/16/2024 4:07 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
04/15/2024 2:44 PM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T/A | |
04/11/2024 5:01 AM | MorphoSys AG (Subject) MorphoSys AG (Subject) Novartis (Filed by)
| Form SC TO-T | |